Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects
Crossref DOI link: https://doi.org/10.1038/s41598-020-77978-z
Published Online: 2020-12-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cho, Jae Min
Yang, Eun Hee
Quan, Wenying
Nam, Eun Hye
Cheon, Hyae Gyeong
Text and Data Mining valid from 2020-12-04
Version of Record valid from 2020-12-04
Article History
Received: 23 June 2020
Accepted: 10 November 2020
First Online: 4 December 2020
Competing interests
: The authors declare no competing interests.